Pregled bibliografske jedinice broj: 1215373
Neonatal screening in Europe revisited: An ISNS perspective on the current state and developments since 2010
Neonatal screening in Europe revisited: An ISNS perspective on the current state and developments since 2010 // International journal of neonatal screening, 7 (2021), 1; 15, 21 doi:10.3390/ijns7010015 (međunarodna recenzija, članak, stručni)
CROSBI ID: 1215373 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Neonatal screening in Europe revisited: An ISNS
perspective on the current state and developments
since 2010
Autori
Loeber, J. Gerard ; Platis, Dimitris ; Zetterström, Rolf H. ; Almashanu, Shlomo ; Boemer, François ; Bonham, James R. ; Borde, Patricia ; Brincat, Ian ; Cheillan, David ; Dekkers, Eugenie ; Dimitrov, Dobry ; Fingerhut, Ralph ; Franzson, Leifur ; Groselj, Urh ; Hougaard, David ; Knapkova, Maria ; Kocova, Mirjana ; Kotori, Vjosa ; Kozich, Viktor ; Kremezna, Anastasiia ; Kurkijärvi, Riikka ; La Marca, Giancarlo ; Mikelsaar, Ruth ; Milenkovic, Tatjana ; Mitkin, Vyacheslav ; Moldovanu, Florentina ; Ceglarek, Uta ; O'Grady, Loretta ; Oltarzewski, Mariusz ; Pettersen, Rolf D. ; Ramadža, Danijela ; Salimbayeva, Damilya ; Samardzic, Mira ; Shamsiddinova, Markhabo ; Songailiené, Jurgita ; Szatmari, Ildiko ; Tabatadze, Nazi ; Tezel, Basak ; Toromanovic, Alma ; Tovmasyan, Irina ; Usurelu, Natalia ; Vevere, Parsla ; Vilarinho, Laura ; Vogazianos, Marios ; Yahyaoui, Raquel ; Zeyda, Maximilian ; Schielen, Peter C.J.I.
Izvornik
International journal of neonatal screening (2409-515X) 7
(2021), 1;
15, 21
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
newborn screening, Europe ; ISNS, rare diseases
Sažetak
Neonatal screening (NBS) was initiated in Europe during the 1960s with the screening for phenylketonuria. The panel of screened disorders ("conditions") then gradually expanded, with a boost in the late 1990s with the introduction of tandem mass spectrometry (MS/MS), making it possible to screen for 40-50 conditions using a single blood spot. The most recent additions to screening programmes (screening for cystic fibrosis, severe combined immunodeficiency and spinal muscular atrophy) were assisted by or realised through the introduction of molecular technologies. For this survey, we collected data from 51 European countries. We report the developments between 2010 and 2020 and highlight the achievements reached with the progress made in this period. We also identify areas where further progress can be made, mainly by exchanging knowledge and learning from experiences in neighbouring countries. Between 2010 and 2020, most NBS programmes in geographical Europe matured considerably, both in terms of methodology (modernised) and with regard to the panel of conditions screened (expanded). These developments indicate that more collaboration in Europe through European organisations is gaining momentum. We can only accomplish the timely detection of newborn infants potentially suffering from one of the many rare diseases and take appropriate action by working together.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Danijela Petković-Ramadža
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus